186 related articles for article (PubMed ID: 34894664)
41. Acidity-Activated Charge Conversion of
Zhang Y; Wang G; Li Q; Jiang Y; Chen W; Zhao M; Liang G; Miao Q
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3875-3884. PubMed ID: 35021621
[TBL] [Abstract][Full Text] [Related]
42. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN
Liang YX; Sun XY; Xu DZ; Gao YN; Tang Q; Lu ZL; Liu Y
ACS Appl Bio Mater; 2024 May; 7(5):3202-3214. PubMed ID: 38651918
[TBL] [Abstract][Full Text] [Related]
43. Chlorin e6-Biotin Conjugates for Tumor-Targeting Photodynamic Therapy.
Liu W; Ma X; Jin Y; Zhang J; Li Y; Tang Y; Song Y; Wang S
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885922
[TBL] [Abstract][Full Text] [Related]
44. Ru(II) Polypyridine Complex-Functionalized Mesoporous Silica Nanoparticles as Photosensitizers for Cancer Targeted Photodynamic Therapy.
Karges J; Díaz-García D; Prashar S; Gómez-Ruiz S; Gasser G
ACS Appl Bio Mater; 2021 May; 4(5):4394-4405. PubMed ID: 35006851
[TBL] [Abstract][Full Text] [Related]
45. Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH.
Zhang Z; Wang R; Huang X; Luo R; Xue J; Gao J; Liu W; Liu F; Feng F; Qu W
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5680-5694. PubMed ID: 31944660
[TBL] [Abstract][Full Text] [Related]
46. Polyphotosensitizer nanogels for GSH-responsive histone deacetylase inhibitors delivery and enhanced cancer photodynamic therapy.
Liu N; Liu H; Chen H; Wang G; Teng H; Chang Y
Colloids Surf B Biointerfaces; 2020 Apr; 188():110753. PubMed ID: 31884084
[TBL] [Abstract][Full Text] [Related]
47. A thermally activated delayed fluorescence photosensitizer for photodynamic therapy of oral squamous cell carcinoma under low laser intensity.
Hu S; Huang B; Pu Y; Xia C; Zhang Q; Guo S; Wang Y; Huang X
J Mater Chem B; 2021 Jul; 9(28):5645-5655. PubMed ID: 34190310
[TBL] [Abstract][Full Text] [Related]
48. Multifunctional Organic Fluorescent Probe with Aggregation-Induced Emission Characteristics: Ultrafast Tumor Monitoring, Two-Photon Imaging, and Image-Guide Photodynamic Therapy.
Ma H; Zhao C; Meng H; Li R; Mao L; Hu D; Tian M; Yuan J; Wei Y
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7987-7996. PubMed ID: 33560829
[TBL] [Abstract][Full Text] [Related]
49. A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy.
Li D; Hu QY; Wang XZ; Li X; Hu JQ; Zheng BY; Ke MR; Huang JD
Bioorg Med Chem Lett; 2020 Jun; 30(12):127164. PubMed ID: 32291134
[TBL] [Abstract][Full Text] [Related]
50. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
51. Synergistic chemo-photodynamic therapy mediated by light-activated ROS-degradable nanocarriers.
Chen Y; Gao Y; Li Y; Wang K; Zhu J
J Mater Chem B; 2019 Jan; 7(3):460-468. PubMed ID: 32254733
[TBL] [Abstract][Full Text] [Related]
52. 808 nm NIR Laser-Excited Upconversion Nanoplatform for Combinatory Photodynamic and Chemotherapy with Deep Penetration and Acid Bursting Release Performance.
Zhong Y; Dong Y; Chen T; Yang L; Yao M; Zhi Y; Yang H; Zhang J; Bi W
ACS Appl Bio Mater; 2021 Mar; 4(3):2639-2653. PubMed ID: 35014380
[TBL] [Abstract][Full Text] [Related]
53. Phenylthiourea-Conjugated BODIPY as an Efficient Photosensitizer for Tyrosinase-Positive Melanoma-Targeted Photodynamic Therapy.
Jung E; Shim I; An J; Ji MS; Jangili P; Chi SG; Kim JS
ACS Appl Bio Mater; 2021 Mar; 4(3):2120-2127. PubMed ID: 35014340
[TBL] [Abstract][Full Text] [Related]
54. Double pH-sensitive nanotheranostics of polypeptide nanoparticle encapsulated BODIPY with both NIR activated fluorescence and enhanced photodynamic therapy.
Dang H; Cheng Q; Tian Y; Teng C; Xie K; Yan L
J Mater Chem B; 2021 Nov; 9(42):8871-8881. PubMed ID: 34693964
[TBL] [Abstract][Full Text] [Related]
55. Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance/photoacoustic/fluorescence imaging-guided synergistic photo-chemotherapy.
Tu L; Fan Z; Zhu F; Zhang Q; Zeng S; Chen Z; Ren L; Hou Z; Ye S; Li Y
J Mater Chem B; 2020 Jul; 8(26):5667-5681. PubMed ID: 32500886
[TBL] [Abstract][Full Text] [Related]
56. Tumor Microenvironment-Responsive Theranostic Nanoplatform for Guided Molecular Dynamic/Photodynamic Synergistic Therapy.
Zhang DY; Huang F; Ma Y; Liang G; Peng Z; Guan S; Zhai J
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17392-17403. PubMed ID: 33829761
[TBL] [Abstract][Full Text] [Related]
57. MnO
Zhang L; Yang R; Yu H; Xu Z; Kang Y; Cui H; Xue P
J Mater Chem B; 2021 May; 9(17):3677-3688. PubMed ID: 33949613
[TBL] [Abstract][Full Text] [Related]
58. Hemoglobin-mediated biomimetic synthesis of paramagnetic O
Shi X; Yang W; Ma Q; Lu Y; Xu Y; Bian K; Liu F; Shi C; Wang H; Shi Y; Zhang B
Theranostics; 2020; 10(25):11607-11621. PubMed ID: 33052236
[TBL] [Abstract][Full Text] [Related]
59. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
60. Ubiquinone-BODIPY nanoparticles for tumor redox-responsive fluorescence imaging and photodynamic activity.
Hwang B; Kim TI; Kim H; Jeon S; Choi Y; Kim Y
J Mater Chem B; 2021 Jan; 9(3):824-831. PubMed ID: 33338098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
